image description

Point-of-care lead testing
means everybody wins.

3 minutes. 2 drops of blood. 1 visit.
Zero loose ends.

LeadCare® II is the only CLIA-waived, point-of-care lead testing system that makes it possible to test, educate and intervene on-the-spot, in one visit. No need to send patients to an outside lab. No need to re-test due to sample problems at the lab. No risk of losing track of a child who needs treatment.

LeadCare II Benefits

image description

Reimbursable.

LeadCare II is reimbursable with CPT code 83655.

image description

1 fingerstick.

Requires just 2 drops of blood. Combines with routine hemoglobin testing.

image description

Saves time.

Eliminates the need to track down lab results & patients for follow up.

image description

Immediate action.

Results in 3 minutes. Test, educate & treat in one visit.

Growing children don’t have time to wait. Neither do you.

Over 535,000 U.S. children have harmful blood lead levels1. Have you found the children at risk in your practice?

Who should be tested?

Federal law requires that all Medicaid eligible children be tested at 12 and 24 months and ages 36 to 72 months if they have not previously been tested.

Each state has guidelines for blood lead testing.  The American  Academy of Pediatrics (AAP) recommends that “children should be tested at least once when they are 2 years of age or, ideally, twice, at 1 and 2 years of age, unless lead exposure can be confidently excluded.”2

Contact us for information to help you determine your state’s specific testing requirements.

Who is at risk for lead exposure? Children are considered at risk if any of the following are true3:

  • Child lives in or frequently visits a home built before 1950, or a recently renovated home built before 1978
  • Child has a sibling or frequent playmate with elevated blood lead levels
  • Child's parent or primary caregiver works with lead. Examples include: battery recycling or manufacture, lead smelting, lead mining, auto repair, shipbuilding, construction, plumbing, and glass manufacture4
  • Child is a recent immigrant, refugee, or foreign adoptee.
  • Child has a household member who uses traditional, folk, or ethnic remedies or cosmetics or who routinely eats food imported informally (e.g., by a family member)

No safe levels. Evidence continues to grow that blood lead levels as low as 5 ug/dL may impair cognition2, with no minimum threshold yet identified.

Lifelong consequences of lead exposure include:

  • Six times higher likelihood of having a reading disability5
  • Being seven times more likely to drop out of high school5
  • Lower scores on neurobehavioral development6
  • Lower scores on tests for math, reading, nonverbal reasoning and short term memory6
  • Hypertension that contributes to adult cardiovascular disease7
  • Decline in IQ with every 1.0 μg/dL increase in blood lead8

Early diagnosis helps to quickly address the effects of lead exposure and provides impetus for lead abatement in homes.

LeadCare II is the only CLIA-waived point-of-care blood lead testing system.  Any employee of an office or lab operating under a CLIA Certificate of Waiver can administer the test.

To request more information or to schedule a product demonstration, contact us.

  1. Wheeler, W. Blood Lead Levels in Children aged 1-5 years - US, 199-2010. Morbidity and Mortality Weekly Report. 2013;62(13):245-247.
  2. American Academy of Pediatrics, Committee on Environmental Health. Lead Exposure in Children:  Prevention, Detection, and Management. Policy Statement. Pediatrics. 2005; 116:1036-1046. Affirmed Jan 2009.
  3. Wengrovitz AM, Brown, MJ. Recommendations for Blood Lead Screening of Medicaid-Eligible Children Aged 1-5 Years: an Updated Approach to Targeting a Group at High Risk.  Morbidity and Mortality Weekly Report. Aug 7, 2009; 58(RR09) 6.  www.cdc.gov/mmwr/pdf/rr/rr5809.pdf. Accessed Jan 2012.
  4. Lead Toxicity: Who is at Risk of Lead Exposure? CDC’s Agency for Toxic Substances and Disease Registry Case Studies in Environmental Medicine (CSEM). www.atsdr.cdc.gov/csem/lead/docs/lead.pdf. Accessed Jan 2012.
  5. Needleman HL. Childhood Exposure to Lead: A Common Cause of School Failure.  Phi Delta Kappan. Sept 1992;74(1): 35-37.
  6. Lanphear BP, Dietrich K, Auinger P, Cox C.  Cognitive Defects Associated with Blood Lead Concentrations <10 µg/dl in U.S. Children and Adolescents. Public Health Reports. Nov/Dec 2000; 115(6): 521-529.
  7. Navas-Acien A., Guallar E, Silbergeld E, Rothenberg S.  Lead Exposure and Cardiovascular Disease – A Systematic Review. Environmental Health Perspectives. March2007;115(3):472-482.
  8. Lanphear BP, Hornung R, Khoury, J et al. Low-Level Environmental Exposure and Children’s Intellectual Function: An International Pooled Analysis. Environ Health Perspect. July 2005; 113 (7); 894-899.

Success Stories

LeadCare II: "It is awesome!"

notes states Rebecca Wright, CPNP
More Success Stories

Request More Information
* = Required

 Security code